389 related articles for article (PubMed ID: 30048982)
21. Availability of pediatric-evaluated formulations in Serbia.
Božić B; Stupar S; Stupar D; Babić U; Bajčetić M
Indian J Pharmacol; 2017; 49(2):189-193. PubMed ID: 28706333
[TBL] [Abstract][Full Text] [Related]
22. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
23. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
[TBL] [Abstract][Full Text] [Related]
24. The interpretation of China national essential medicines list 2018.
Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
[No Abstract] [Full Text] [Related]
25. Biologic medicine inclusion in 138 national essential medicines lists.
Kraus R; Yeung RSM; Persaud N
Pediatr Rheumatol Online J; 2021 Sep; 19(1):140. PubMed ID: 34488779
[TBL] [Abstract][Full Text] [Related]
26. [The essentiality and rationality of the Brazilian national listing of essential medicines].
Yamauti SM; Bonfim JR; Barberato-Filho S; Lopes LC
Cien Saude Colet; 2017 Mar; 22(3):975-986. PubMed ID: 28301004
[TBL] [Abstract][Full Text] [Related]
27. [Concordance between essential medicines lists and diabetes guidelines in Latin America and the CaribbeanConcordância entre as listas de medicamentos essenciais e diretrizes para diabetes na América Latina e no Caribe].
Urtasun MA; Dorati C; Cañás M; Bruzzone MS; Marín GH; Iusef Venturini N; Mordujovich Buschiazzo P
Rev Panam Salud Publica; 2024; 48():e3. PubMed ID: 38352034
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in the systems of pediatric diabetes care across the European Union.
Cinek O; Sumník Z; de Beaufort C; Rurik I; Vazeou A; Madácsy L; Papo NL; Danne T;
Pediatr Diabetes; 2012 Sep; 13 Suppl 16():5-14. PubMed ID: 22931219
[TBL] [Abstract][Full Text] [Related]
29. Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.
Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(9):e106072. PubMed ID: 25259517
[TBL] [Abstract][Full Text] [Related]
30. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
32. OS032. Pharmacotherapy for pre-eclampsia in low and middle income countries: An analysis of essential medicines lists (EMLS).
Lalani S; Firoz T; Magee LA; Lowe R; Sawchuck D; Payne B; Gordon R; Vidler M; von Dadelszen P
Pregnancy Hypertens; 2012 Jul; 2(3):193-4. PubMed ID: 26105246
[TBL] [Abstract][Full Text] [Related]
33. Essential Medicines in National Constitutions: Progress Since 2008.
Katrina Perehudoff S; Toebes B; Hogerzeil H
Health Hum Rights; 2016 Jun; 18(1):141-156. PubMed ID: 27781006
[TBL] [Abstract][Full Text] [Related]
34. Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.
Magarinos-Torres R; Lynd LD; Luz TCB; Marques PEPC; Osorio-de-Castro CGS
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):181-188. PubMed ID: 28371342
[TBL] [Abstract][Full Text] [Related]
35. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
36. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
[TBL] [Abstract][Full Text] [Related]
37. Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.
Mujinja PG; Mackintosh M; Justin-Temu M; Wuyts M
Global Health; 2014 Mar; 10():12. PubMed ID: 24612518
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda.
Masters SH; Burstein R; DeCenso B; Moore K; Haakenstad A; Ikilezi G; Achan J; Osei I; Garshong B; Kisia C; Njuguna P; Babigumira J; Kumar S; Hanlon M; Gakidou E
PLoS One; 2014; 9(12):e114762. PubMed ID: 25500832
[TBL] [Abstract][Full Text] [Related]
39. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
Barr R; Robertson J
Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
[TBL] [Abstract][Full Text] [Related]
40. [Adherence to essential medicines in cities from three Brazilian states].
Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
